AU2011223807B2 - Methods and compositions for treating or preventing symptoms of hormonal variations - Google Patents

Methods and compositions for treating or preventing symptoms of hormonal variations Download PDF

Info

Publication number
AU2011223807B2
AU2011223807B2 AU2011223807A AU2011223807A AU2011223807B2 AU 2011223807 B2 AU2011223807 B2 AU 2011223807B2 AU 2011223807 A AU2011223807 A AU 2011223807A AU 2011223807 A AU2011223807 A AU 2011223807A AU 2011223807 B2 AU2011223807 B2 AU 2011223807B2
Authority
AU
Australia
Prior art keywords
symptoms
dextromethorphan
hormonal
hot flashes
sub
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2011223807A
Other languages
English (en)
Other versions
AU2011223807A1 (en
Inventor
George E. Royster Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FERVENT PHARMACEUTICALS LLC
Original Assignee
FERVENT PHARMACEUTICALS LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FERVENT PHARMACEUTICALS LLC filed Critical FERVENT PHARMACEUTICALS LLC
Publication of AU2011223807A1 publication Critical patent/AU2011223807A1/en
Application granted granted Critical
Publication of AU2011223807B2 publication Critical patent/AU2011223807B2/en
Priority to AU2016213776A priority Critical patent/AU2016213776B2/en
Priority to AU2018205147A priority patent/AU2018205147A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2011223807A 2010-03-02 2011-03-01 Methods and compositions for treating or preventing symptoms of hormonal variations Active AU2011223807B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2016213776A AU2016213776B2 (en) 2010-03-02 2016-08-10 Methods and compositions for treating or preventing symptoms of hormonal variations
AU2018205147A AU2018205147A1 (en) 2010-03-02 2018-07-12 Methods and compositions for treating or preventing symptoms of hormonal variations

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30963810P 2010-03-02 2010-03-02
US61/309,638 2010-03-02
PCT/US2011/026650 WO2011109367A2 (en) 2010-03-02 2011-03-01 Methods and compositions for treating or preventing symptoms of hormonal variations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2016213776A Division AU2016213776B2 (en) 2010-03-02 2016-08-10 Methods and compositions for treating or preventing symptoms of hormonal variations

Publications (2)

Publication Number Publication Date
AU2011223807A1 AU2011223807A1 (en) 2012-10-18
AU2011223807B2 true AU2011223807B2 (en) 2016-05-12

Family

ID=44531862

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2011223807A Active AU2011223807B2 (en) 2010-03-02 2011-03-01 Methods and compositions for treating or preventing symptoms of hormonal variations
AU2016213776A Active AU2016213776B2 (en) 2010-03-02 2016-08-10 Methods and compositions for treating or preventing symptoms of hormonal variations
AU2018205147A Abandoned AU2018205147A1 (en) 2010-03-02 2018-07-12 Methods and compositions for treating or preventing symptoms of hormonal variations

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2016213776A Active AU2016213776B2 (en) 2010-03-02 2016-08-10 Methods and compositions for treating or preventing symptoms of hormonal variations
AU2018205147A Abandoned AU2018205147A1 (en) 2010-03-02 2018-07-12 Methods and compositions for treating or preventing symptoms of hormonal variations

Country Status (12)

Country Link
US (1) US20110218213A1 (enExample)
EP (1) EP2542241B1 (enExample)
JP (1) JP5839362B2 (enExample)
CN (1) CN102858343B (enExample)
AU (3) AU2011223807B2 (enExample)
BR (1) BR112012022052B1 (enExample)
CA (1) CA2828041C (enExample)
EA (1) EA027350B1 (enExample)
ES (1) ES2574210T3 (enExample)
IL (2) IL221706A (enExample)
PL (1) PL2542241T3 (enExample)
WO (1) WO2011109367A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9616123B1 (en) * 2012-03-05 2017-04-11 Robert L. Knobler Method and compound for treatment of menopausal symptoms
CA2980990A1 (en) * 2015-04-07 2016-10-13 Meiji Co., Ltd. Hot flash-suppressing agent
US11622948B2 (en) 2017-11-09 2023-04-11 The Trustees Of Columbia University In The City Of New York Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders
US11491120B2 (en) 2017-11-09 2022-11-08 The Trustees Of Columbia University In The City Of New York Pharmacological prophylactics against stress-induced affective disorders in females
JP2022532851A (ja) * 2019-04-22 2022-07-20 エル クノブラー、ロバート ホットフラッシュの非ホルモン治療
WO2021108801A2 (en) * 2019-11-15 2021-06-03 Consegna Pharma, Inc. Long acting nmda antagonists

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654008A (en) * 1993-11-19 1997-08-05 Alkermes Controlled Therapeutics Inc. Ii Preparation of biodegradable microparticles containing a biologically active agent
US6310098B1 (en) * 1999-07-22 2001-10-30 University Of Rochester Method of treating symptoms of hormonal variation, including hot flashes
US20050129783A1 (en) * 2001-04-19 2005-06-16 Mccleary Edward L. Composition and method for treatment of neurophysiological conditions and maintenance of neurophysiological health
US20080146541A1 (en) * 2006-12-13 2008-06-19 Hung-Ming Wu Methods for treating or preventing sysmptoms of hormonal variations
US20090111846A1 (en) * 2006-02-03 2009-04-30 Avanir Pharmaceuticals Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of depression, anxiety, and neurodegenerative disorders

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
CA2115792C (en) * 1993-03-05 2005-11-01 David J. Mayer Method for the treatment of pain
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US6569471B2 (en) * 2000-09-01 2003-05-27 Natumin Pharma Ab Method for the treatment of symptoms related to normal hormonal variations in women
US20040259850A1 (en) * 2001-10-31 2004-12-23 Alves Stephen E. Method for treating or preventing symptoms of hormonal variation including hot flashes
RU2340333C2 (ru) * 2002-08-15 2008-12-10 Вайет Агонизм 5нт2a -рецептора для лечения нарушения функции терморегуляции
HUP0303313A2 (hu) * 2003-10-09 2005-07-28 Richter Gedeon Vegyészeti Gyár Rt. Transzdermális gyógyszerkészítmények
US7855195B2 (en) * 2003-12-02 2010-12-21 Pharmaneuroboost N.V. Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
WO2005107808A2 (en) * 2004-05-11 2005-11-17 Pfizer Products Inc. Combination of atypical antipsychotics and 5-ht1b receptor antagonists
EP1758600A4 (en) * 2004-06-04 2008-03-05 Mood Man Sciences Llc METHOD AND COMPOSITIONS FOR TREATING MUTUAL DISORDER
US20060122127A1 (en) * 2004-11-17 2006-06-08 Cypress Bioscience, Inc. Methods for reducing the side effects associated with mirtzapine treatment
CN101257907A (zh) * 2005-07-06 2008-09-03 塞普拉科公司 左旋佐匹克隆和抗抑郁剂的组合
EP1969117A4 (en) * 2005-12-13 2008-12-17 Trinity Lab Inc A method to treat premature ejaculation in humans
WO2008116024A2 (en) * 2007-03-19 2008-09-25 Acadia Pharmaceuticals Inc. Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics
EP2323688B1 (en) * 2008-07-22 2018-10-17 MenoGeniX, Inc. Compositions and methods for treating symptoms associated with menopause, hormonal variations and arthritis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654008A (en) * 1993-11-19 1997-08-05 Alkermes Controlled Therapeutics Inc. Ii Preparation of biodegradable microparticles containing a biologically active agent
US6310098B1 (en) * 1999-07-22 2001-10-30 University Of Rochester Method of treating symptoms of hormonal variation, including hot flashes
US20050129783A1 (en) * 2001-04-19 2005-06-16 Mccleary Edward L. Composition and method for treatment of neurophysiological conditions and maintenance of neurophysiological health
US20090111846A1 (en) * 2006-02-03 2009-04-30 Avanir Pharmaceuticals Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of depression, anxiety, and neurodegenerative disorders
US20080146541A1 (en) * 2006-12-13 2008-06-19 Hung-Ming Wu Methods for treating or preventing sysmptoms of hormonal variations

Also Published As

Publication number Publication date
AU2016213776B2 (en) 2018-04-12
EA027350B1 (ru) 2017-07-31
BR112012022052B1 (pt) 2021-06-29
WO2011109367A3 (en) 2011-12-29
BR112012022052A2 (pt) 2020-07-07
IL253853A0 (en) 2017-09-28
WO2011109367A4 (en) 2012-02-23
IL253853B (en) 2019-05-30
CN102858343B (zh) 2015-11-25
EP2542241A2 (en) 2013-01-09
PL2542241T3 (pl) 2016-12-30
AU2016213776A1 (en) 2016-09-01
EP2542241B1 (en) 2016-04-27
CN102858343A (zh) 2013-01-02
IL221706A (en) 2017-08-31
WO2011109367A2 (en) 2011-09-09
EA201290851A1 (ru) 2013-04-30
JP2013521297A (ja) 2013-06-10
CA2828041C (en) 2018-04-17
AU2018205147A1 (en) 2018-08-02
US20110218213A1 (en) 2011-09-08
AU2011223807A1 (en) 2012-10-18
CA2828041A1 (en) 2011-09-09
EP2542241A4 (en) 2013-11-06
JP5839362B2 (ja) 2016-01-06
ES2574210T3 (es) 2016-06-15

Similar Documents

Publication Publication Date Title
US9457022B2 (en) Methods and compositions for treating or preventing symptoms of hormonal variations
AU2016213776B2 (en) Methods and compositions for treating or preventing symptoms of hormonal variations
US8420624B2 (en) Methods for treating or preventing symptoms of hormonal variations
EP2101781B1 (en) Method for treating or preventing symptoms of hormonal variations
US20110124617A1 (en) Combination Therapy for BreastCancer Comprising an Antiestrogenic Agent
CA2502027A1 (en) A method of treating vasomotor symptoms comprising a compound having norepinephrine reuptake inhibitor activity and 5-ht2a antagonistic activity
WO2008037045A2 (en) Composition containing a mixture of antidepressants for treating premature ejaculation.
RS57150B1 (sr) Lečenje menopauzalnih valunga ropinirolom i tizanidinom
EA011926B1 (ru) Пероральный антидепрессивный состав, включающий ацетилсалициловую кислоту для ускорения начала действия
CN1705475A (zh) 通过具有去甲肾上腺素重摄取抑制剂活性和5－ht2a拮抗活性的化合物治疗血管舒缩症的方法

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)